Compare StocksGS vs HCA

The Goldman Sachs Group, Inc. (GS) vs HCA Healthcare, Inc. (HCA): Which Is the Better Buy in 2026?

As of 2026-06-19, GS is undervalued at $1097, with a DCF intrinsic value of $2507 and a margin of safety of 56%. HCA is undervalued at $375, with an intrinsic value of $523 and a margin of safety of 28%. Of the two, GS has the wider margin of safety.

GS
The Goldman Sachs Group, Inc.
$1096.56
VS
HCA
HCA Healthcare, Inc.
$375.17

Rewards

GS
  • Gross margin of 82.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Share count has been reduced by 11% over the past 4 years through buybacks, increasing each share's claim on earnings.
  • Each dollar of retained earnings has created $2.58 of earning power — management is an exceptional capital allocator.
HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

GS
  • Trailing P/E of 20.0x is 36% above the historical average of 14.7x — the stock trades at a premium to its own history.
  • Altman Z-Score of 0.25 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • 7 insider sales totaling $35.6M with no purchases in the past 3 months — insiders are reducing their exposure.
HCA

    Key Valuation Metrics

    Learn more →
    GS
    HCA
    Valuation
    N/A
    Free Cash Flow
    $7.69B
    N/A
    FCF Yield
    9.24%
    20.03
    Trailing P/E
    12.93
    16.71
    Forward P/E
    11.33
    Quality & Moat
    1.95%
    ROIC
    18.14%
    14.55%
    ROE
    N/A
    82.27%
    Gross Margin
    41.61%
    1.68
    PEG Ratio
    1.20
    Balance Sheet Safety
    Net cash
    Net Debt / Equity
    N/A
    N/A
    Interest Coverage
    N/A
    N/A
    Net Debt / EBITDA
    3.13
    1.65%
    Dividend Yield
    0.76%
    GS: 2Ties: 1HCA: 4
    GSHCA

    Historical Fundamentals

    Learn more →
    GS

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    HCA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    GS
    $5.60
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $26.00B
    Δ Market Cap
    +$145.60B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    HCA
    $2.43
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $15.76B
    Δ Market Cap
    +$38.30B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    GS
    56.3% Margin of Safety
    Price is 56.3% below estimated fair value
    Current Price: $1096.56
    Fair Value: $2506.96
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    HCA
    28.2% Margin of Safety
    Price is 28.2% below estimated fair value
    Current Price: $375.17
    Fair Value: $522.55
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    GS

    Requires positive FCF to compute implied growth rate.

    HCA

    What growth rate is the market pricing in at $375?

    +7.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +5.6%

    The market implies +7.3% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +5.6%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    GS
    65/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with reinvestment efficiency as the key competitive advantage. Improving margin stability would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    HCA
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    GS
    -2.00
    Possible Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    HCA
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    GS
    Insiders 0.5%Institutions 74.6%Retail & Other 24.8%
    No. of Institutional Holders3,780
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    HCA
    Insiders 16.2%Institutions 78.3%Retail & Other 5.5%
    No. of Institutional Holders1,952
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    GS
    0
    Buys (3M)
    0
    Buys (12M)
    HESS JOHN B JR.
    Director
    $2.00M
    @ $511.68 · 2025-04-15
    JOHNSON KEVIN RONALD
    Director
    $1.49M
    @ $619.02 · 2025-01-17
    FLAHERTY MARK A
    Director
    $29,545
    @ $360.30 · 2024-09-27
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    HCA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    GS
    7
    Sells (3M)
    17
    Sells (12M)
    Total value (12M): $92.56M
    COLEMAN DENIS P.
    Chief Financial Officer
    $6.68M
    @ $973.55 · 2026-05-14
    RUEMMLER KATHRYN H
    General Counsel
    $13.42M
    @ $939.07 · 2026-05-06
    FREDMAN SHEARA J.
    Officer
    $9.57M
    @ $929.17 · 2026-05-01
    RUEMMLER KATHRYN H
    General Counsel
    $634,927
    @ $929.61 · 2026-05-01
    SOLOMON DAVID M
    Chief Executive Officer
    $3.23M
    @ $930.70 · 2026-05-01
    GOLTEN ALEXANDER SIMON
    Officer
    $1.04M
    @ $936.18 · 2026-04-23
    GOLTEN ALEXANDER SIMON
    Officer
    $1.02M
    @ $919.19 · 2026-04-17
    COLEMAN DENIS P.
    Chief Financial Officer
    $10.94M
    @ $941.57 · 2026-02-09
    SOLOMON DAVID M
    Chief Executive Officer
    $255,387
    @ $938.92 · 2026-01-29
    HALIO CAREY
    Officer
    $2.64M
    @ $927.17 · 2026-01-27
    FREDMAN SHEARA J.
    Officer
    $4.49M
    @ $923.75 · 2026-01-23
    RUEMMLER KATHRYN H
    General Counsel
    $8.89M
    @ $927.51 · 2026-01-23
    HALIO CAREY
    Officer
    $1.62M
    @ $920.62 · 2026-01-23
    WALDRON JOHN E.
    President
    $13.69M
    @ $750.30 · 2025-08-28
    COLEMAN DENIS P.
    Chief Financial Officer
    $5.41M
    @ $724.40 · 2025-07-25
    SOLOMON DAVID M
    Chief Executive Officer
    $4.71M
    @ $712.31 · 2025-07-23
    ROGERS JOHN F W
    Officer
    $4.31M
    @ $717.39 · 2025-07-23
    SOLOMON DAVID M
    Chief Executive Officer
    $3.04M
    @ $607.17 · 2025-05-14
    SOLOMON DAVID M
    Chief Executive Officer
    $1.50M
    @ $622.15 · 2025-02-26
    GOLTEN ALEXANDER SIMON
    Officer
    $3.31M
    @ $636.25 · 2025-01-28
    HALIO CAREY
    Officer and Treasurer
    $2.32M
    @ $636.74 · 2025-01-24
    FREDMAN SHEARA J.
    Officer
    $1.28M
    @ $627.01 · 2025-01-21
    RUEMMLER KATHRYN H
    General Counsel
    $4.76M
    @ $634.69 · 2025-01-21
    HALIO CAREY
    Officer
    $965,120
    @ $624.67 · 2025-01-21
    VINIAR DAVID A
    Director
    $3.06M
    @ $612.08 · 2024-11-29
    SOLOMON DAVID M
    Chief Executive Officer
    $4.00M
    @ $610.91 · 2024-11-29
    FREDMAN SHEARA J.
    Officer
    $1.77M
    @ $594.51 · 2024-11-06
    COLEMAN DENIS P.
    Chief Financial Officer
    $7.67M
    @ $593.03 · 2024-11-06
    ROGERS JOHN F W
    Officer
    $3.83M
    @ $596.36 · 2024-11-06
    SOLOMON DAVID M
    Chief Executive Officer
    $3.00M
    @ $500.29 · 2024-08-15
    VINIAR DAVID A
    Director
    $2.51M
    @ $502.43 · 2024-07-16
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    HCA
    0
    Sells (3M)
    7
    Sells (12M)
    Total value (12M): $32.73M
    MCALEVEY MICHAEL R.
    Officer
    $903,537
    @ $533.37 · 2026-02-18
    WYATT CHRISTOPHER F
    Officer
    $2.02M
    @ $505.00 · 2026-02-11
    BERRES JENNIFER
    Officer
    $4.13M
    @ $514.58 · 2026-02-11
    HAZEN SAMUEL N
    Chief Executive Officer
    $21.48M
    @ $501.04 · 2026-02-03
    CUFFE MICHAEL S
    Officer
    $747,135
    @ $498.09 · 2026-02-03
    MCALEVEY MICHAEL R.
    Officer
    $1.84M
    @ $473.79 · 2025-11-05
    CUFFE MICHAEL S
    Officer
    $1.61M
    @ $418.84 · 2025-09-08
    FOSTER JON MARK
    Officer
    $5.80M
    @ $369.32 · 2025-05-13
    BERRES JENNIFER
    Officer
    $3.08M
    @ $322.59 · 2025-02-14
    BILLINGTON PHILLIP G
    Officer
    $1.36M
    @ $350.00 · 2024-11-14
    WHALEN KATHLEEN M
    Officer
    $527,677
    @ $357.99 · 2024-11-14
    AKDAMAR EROL R
    Officer
    $1.02M
    @ $353.00 · 2024-11-14
    CUFFE MICHAEL S
    Officer
    $3.22M
    @ $385.42 · 2024-09-12
    WHALEN KATHLEEN M
    Officer
    $1.76M
    @ $362.13 · 2024-07-31
    WYATT CHRISTOPHER F
    Officer
    $1.44M
    @ $360.20 · 2024-07-29
    REINER DEBORAH M
    Officer
    $1.19M
    @ $359.96 · 2024-07-29
    TORRES KATHRYN A
    Officer
    $659,328
    @ $355.05 · 2024-07-25
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    GS
    FearGreed
    😏Greed(66/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    HCA
    FearGreed
    😨Fear(39/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    GS
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (66)
    HCA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
    View GS Full AnalysisView HCA Full Analysis

    Frequently Asked Questions: GS vs HCA

    Is The Goldman Sachs Group, Inc. or HCA Healthcare, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, GS trades at a 56.3% margin of safety (intrinsic value $2507 vs. price $1097), compared to HCA's 28.2% margin of safety (intrinsic $523 vs. $375).

    Which stock has a wider economic moat, The Goldman Sachs Group, Inc. or HCA Healthcare, Inc.?

    HCA scores 95/100 (Wide moat), while GS scores 65/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is The Goldman Sachs Group, Inc. in financial distress?

    GS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. HCA scores 2.7 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, The Goldman Sachs Group, Inc. or HCA Healthcare, Inc.?

    HCA earns 18.1% ROIC versus GS's 1.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, The Goldman Sachs Group, Inc.'s or HCA Healthcare, Inc.'s?

    HCA's dividend earns a safety score of 94/100 (Very Safe), compared to GS's 79/100 (Safe). HCA has raised its dividend for 3 consecutive years.